Viridian Therapeutics, Inc.\DE (VRDN) Common Stock, Shares, Issued 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Viridian Therapeutics, Inc.\DE quarterly Common Stock, Shares, Issued history and growth rate from 2013 to 2024.
  • Viridian Therapeutics, Inc.\DE Common Stock, Shares, Issued for the quarter ending March 31, 2024 was 63.8M shares, a 48.2% increase year-over-year.
Common Stock, Shares, Issued, Quarterly Data (shares)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 63.8M +20.7M +48.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 54M +12.7M +30.7% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 43.7M +3.46M +8.59% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 43.6M +15.1M +53% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 43.1M +15.9M +58.5% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 41.3M +17.4M +72.7% Dec 31, 2022 10-K 2024-02-27
Q3 2022 40.2M +20.9M +108% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 28.5M +19.9M +231% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 27.2M +19.9M +276% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 23.9M +19.7M +465% Dec 31, 2021 10-K 2023-03-09
Q3 2021 19.4M -37.7M -66.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 8.61M -44.5M -83.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 7.23M -45.8M -86.4% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 4.23M +1.91M +82.1% Dec 31, 2020 10-K 2022-03-11
Q3 2020 57.1M +25.9M +83% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 53.1M +22M +71% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 53.1M +22.2M +71.7% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 2.32M -28.5M -92.5% Dec 31, 2019 10-K 2021-03-26
Q3 2019 31.2M +348K +1.13% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 31M +442K +1.44% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 30.9M +735K +2.43% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 30.8M +8.27M +36.7% Dec 31, 2018 10-K 2020-03-13
Q3 2018 30.8M +8.95M +40.9% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 30.6M +9.11M +42.4% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 30.2M +8.78M +41% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 22.6M +21.7M +2607% Dec 31, 2017 10-K 2019-03-14
Q3 2017 21.9M +11.1M +103% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 21.5M +10.7M +99.3% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 21.4M +10.7M +99.8% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 834K +125K +17.6% Dec 31, 2016 10-K 2018-03-15
Q3 2016 10.8M +155K +1.46% Sep 30, 2016 10-Q 2016-10-26
Q2 2016 10.8M +2.93M +37.4% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 10.7M +3.2M +42.7% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 709K -3.07M -81.3% Dec 31, 2015 10-K 2017-03-24
Q3 2015 10.6M +6.85M +181% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 7.85M +4.06M +107% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 7.5M Mar 31, 2015 10-Q 2015-05-15
Q4 2014 3.78M +3.78M Dec 31, 2014 10-K 2016-03-21
Q3 2014 3.78M Sep 30, 2014 10-Q 2014-11-14
Q2 2014 3.78M Jun 30, 2014 10-Q 2014-08-14
Q4 2013 0 Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.